astria therapeutics glp-1 receptor agonist weight management diabetes treatments for vs GLP-1 for Loss: What's Changing for Patients and Pharmacies? GLP-1 therapies: a new frontier
Description
Awareness prevents these issues
A 2024 network meta-analysis across 11 randomised trials found semaglutide was associated with approximately 17.67 kg greater weight loss versus placebo, outperforming liraglutide, exenatide, and dulaglutide in head-to-head comparisons [5]
(N Y) 2 (11), 12031230
Zhu R, Tang J, Xing C, et al
However, there is uncertainty around their effects when used in pregnancy
